clinical trial · NCT06760611
Tissue Quality of Integra vs. BTM Treated Burns
Burn InjuryBurn ScarBurn Wounds - Partial Thickness (2nd Degree)Skin Grafting
brief summary
An observational analysis of Integra-treated burns and Novosorb Biodegradable Temporizing Matrix (BTM)-treated burns will be undertaken 12-36 months post final skin graft application by retrospectively analyzing the patient's electronic medical record, and prospectively using a non-invasive measures of tissue quality and patient-reported outcomes. Patients will be offered the option to consent for a tissue biopsy for pathological evaluation.
started
Mar 1, 2025
primary completion
Sep 30, 2025
completion
Sep 30, 2025
last updated
Jan 7, 2026
official title
An Observational Cohort Analysis of Tissue Quality of Integra Dermal Matrix (Integra®)-Treated Burns and NovoSorb® Biodegradable Temporizing Matrix (BTM)-Treated Burns 12-36 Months Post Final Skin Graft Application
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol